Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cochlear Ltd.

www.cochlear.com

Latest From Cochlear Ltd.

ResMed Jumps On Board As Nyxoah Raises €25m For Neurostim Apnea Device

The proceeds from the investment will enable Nyxoah to prepare for the IDE pivotal trial of the Genio system in the US, and accelerate market access and commercialization activities in Europe, Australia and New Zealand.

Financing Clinical Trials

Global Device Approvals Snapshot: 11-17 June 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker, including a PMA supplement for Agilent’s PD-L1 IHC 22C3 pharmDx companion diagnostic for Merck’s Keytruda (pembrolizumab), an anti-PD-1 drug, for patients with head and neck squamous cell carcinoma. The US FDA also approved a supplement for the Cochlear Nucleus Profile Plus Series Cochlear Implant, designed to be safe with magnetic resonance imaging.

Approvals Innovation

Cochlear Combines With Sensorion To Explore Hearing-Loss Treatments

Cochlear Ltd. has formed an alliance with French biotech company Sensorion to explore if a combination drug/hearing implant can improve the treatment of hearing loss. The collaboration moves Cochlear outside of its device field and could see it obtain a global license for Sensorion's SENS-401 drug candidate.

Commercial Companies

DEVICE DEBUTS: Product And New Indication Launches From Medtronic, Strkyer, Siemens, And More

This month's edition of Device Debuts includes new product launches from Medtronic, Cochlear, Qualcomm, Titan Spine, Stryker, Philips, Nuance, Nevro, Siemens, Vortex BioSciences, ResMed, Respircardia, and others.

Innovation Companies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Otolaryngology > Deafness
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Cochlear Ltd.
  • Senior Management
  • Chris Roberts, PhD, Pres. & CEO
    Neville Mitchell, CFO
    Jan Janssen, SVP, Design & Dev.
    Michael Kavanagh, SVP, Global Mktg.
  • Contact Info
  • Cochlear Ltd.
    Phone: (61) 2 9428 6555
    14 Mars Rd.
    P.O. Box 629 Lane Cove, NSW 2066
    Australia
UsernamePublicRestriction

Register